Featured Research

from universities, journals, and other organizations

Donor Risk Index does not impact outcomes on a small scale, study finds

Date:
August 16, 2010
Source:
Henry Ford Health System
Summary:
The Donor Risk Index, which assesses donor characteristics impacting liver transplantation outcomes, does not bear the same impact on outcomes on a small scale as is suggested from large-scale, national data. Rather, hepatitis C was shown to continue to be the major contributor to poor graft survival in transplant patients, according to a new study.

The Donor Risk Index, which assesses donor characteristics impacting liver transplantation outcomes, does not bear the same impact on outcomes on a small scale as is suggested from large-scale, national data.

Related Articles


Rather, hepatitis C was shown to continue to be the major contributor to poor graft survival in transplant patients, according to a Henry Ford Hospital study.

The goals of the study were to confirm the effect of the Donor Risk Index on liver transplant recipients and to evaluate further donor and recipient characteristics on transplant outcomes.

"We found the risks to be small for individual characteristics influencing outcomes except for hepatitis C," says Marwan Abouljoud, M.D., director of Henry Ford Hospital's Transplant Institute and lead author of the study.

"Looking at data from large studies is like looking under a microscope and when the information from many of these national studies is translated to day-to-day practice, the information often doesn't prove to be practical, especially when you consider patients are dying on transplant waiting lists."

Study results were presented at the International Congress of The Transplantation Society in Vancouver.

The study looked at the DRI scores for 100 liver transplants between January and December 2008, analyzing recipients and their corresponding donors. Donor and recipient demographics, model for end-stage liver disease (MELD) scores, laboratory data, operative factors and pathologists were reviewed.

The presence of hepatitis in recipients post-transplant was found to have the biggest impact on mortality and graft failure. Death rate was 22 percent, of which 41 percent died due to recurrent hepatitis. The graft failure rate was 20 percent with hepatitis the cause in 44 percent of the cases.

The only Donor Risk Index subcategory that was associated with graft loss in the study was high donor age, says Dr. Abouljoud, who suggests that further study is needed to favorably impact graft survival within the context of the Donor Risk Index.

"Our findings suggest that the focus should be on the combined factors that effect organ quality and function, not one individual characteristic," says Dr. Abouljoud.

Currently, almost 16,000 people in the United States are waiting for liver transplants, according to the Health Resources and Services Administration. About 5,300 liver transplantations were performed in the United States in 2002.

The study was funded by Henry Ford Transplant Institute.


Story Source:

The above story is based on materials provided by Henry Ford Health System. Note: Materials may be edited for content and length.


Cite This Page:

Henry Ford Health System. "Donor Risk Index does not impact outcomes on a small scale, study finds." ScienceDaily. ScienceDaily, 16 August 2010. <www.sciencedaily.com/releases/2010/08/100816122202.htm>.
Henry Ford Health System. (2010, August 16). Donor Risk Index does not impact outcomes on a small scale, study finds. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2010/08/100816122202.htm
Henry Ford Health System. "Donor Risk Index does not impact outcomes on a small scale, study finds." ScienceDaily. www.sciencedaily.com/releases/2010/08/100816122202.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Rural India's Low-Cost Sanitary Pad Revolution

Rural India's Low-Cost Sanitary Pad Revolution

AFP (Nov. 28, 2014) — One man hopes his invention -– a machine that produces cheap sanitary pads –- will help empower Indian women. Duration: 01:51 Video provided by AFP
Powered by NewsLook.com
Research on Bats Could Help Develop Drugs Against Ebola

Research on Bats Could Help Develop Drugs Against Ebola

AFP (Nov. 28, 2014) — In Africa's only biosafety level 4 laboratory, scientists have been carrying out experiments on bats to understand how virus like Ebola are being transmitted, and how some of them resist to it. Duration: 01:18 Video provided by AFP
Powered by NewsLook.com
WHO Says Male Ebola Survivors Should Abstain From Sex

WHO Says Male Ebola Survivors Should Abstain From Sex

Newsy (Nov. 28, 2014) — WHO cites four studies that say Ebola can still be detected in semen up to 82 days after the onset of symptoms. Video provided by Newsy
Powered by NewsLook.com
Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins